Sort   by:  
 Page size 
UnknownSafety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial.
Not available
S-EPMC8655533 | biostudies-literature
UnknownIncreased Motility and Suppression of Ex Vivo-Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis.
Not available
S-EPMC10285232 | biostudies-literature
UnknownDetecting long-range interactions between migrating cells.
Not available
S-EPMC8298713 | biostudies-literature
UnknownIntestinal Mucosal Wound Healing and Barrier Integrity in IBD-Crosstalk and Trafficking of Cellular Players.
Not available
S-EPMC8021701 | biostudies-literature
UnknownA Chimeric IL-15/IL-15Rα Molecule Expressed on NFκB-Activated Dendritic Cells Supports Their Capability to Activate Natural Killer Cells.
Not available
S-EPMC8508776 | biostudies-literature
UnknownCirculating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19.
Not available
S-EPMC8093414 | biostudies-literature
UnknownTransfer of bone marrow niche-residential regulatory T cells ameliorates experimental colitis.
Not available
S-EPMC12947311 | biostudies-literature
UnknownDevelopment and Validation of a Prediction Model for Prehospital Triage of Trauma Patients.
Not available
S-EPMC6537785 | biostudies-literature
UnknownDifferential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo.
Not available
S-EPMC5036234 | biostudies-literature
UnknownGood Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders.
Not available
S-EPMC5662555 | biostudies-literature
Sort   by:  
 Page size